110 related articles for article (PubMed ID: 21345303)
21. Adalimumab in juvenile rheumatoid arthritis.
Taddio A; Marchetti F
N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
[No Abstract] [Full Text] [Related]
22. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
[No Abstract] [Full Text] [Related]
23. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
24. Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis.
Lin T; Wang C; Cai XZ; Zhao X; Shi MM; Ying ZM; Yuan FZ; Guo C; Yan SG
Int J Clin Pract; 2012 Apr; 66(4):399-408. PubMed ID: 22313934
[TBL] [Abstract][Full Text] [Related]
25. Nocardia infection with adalimumab in rheumatoid arthritis.
Doraiswamy VA
J Rheumatol; 2008 Mar; 35(3):542-3. PubMed ID: 18322980
[No Abstract] [Full Text] [Related]
26. Adalimumab for rheumatoid arthritis?
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
[No Abstract] [Full Text] [Related]
27. Absence of radiographic progression at two years in a cohort of patients with non-radiographic axial spondyloarthritis treated with TNF-α blockers.
Almirall M; López-Velandia JG; Maymó J
Reumatol Clin; 2014; 10(2):134-5. PubMed ID: 23827199
[No Abstract] [Full Text] [Related]
28. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab.
Puxeddu I; Giori L; Rocchi V; Bazzichi L; Bombardieri S; Tavoni A; Migliorini P; Del Corso I
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):123-4. PubMed ID: 22289732
[No Abstract] [Full Text] [Related]
29. Sustained efficacy and safety of adalimumab in psoriasis treatment: a retrospective study of 49 patients with and without a history of TNF-alpha antagonist treatment.
Van L; Modi SV; Yang DJ; Hsu S
Arch Dermatol; 2008 Jun; 144(6):804-6. PubMed ID: 18559778
[No Abstract] [Full Text] [Related]
30. Adalimumab in juvenile rheumatoid arthritis.
Sfriso P; Ravaioli F
N Engl J Med; 2008 Dec; 359(23):2495; author reply 2496-7. PubMed ID: 19052133
[No Abstract] [Full Text] [Related]
31. Which TNF inhibitor for rheumatoid arthritis?
Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
[No Abstract] [Full Text] [Related]
32. Pityriasis rubra pilaris successfully treated with adalimumab.
Schreml S; Zeller V; Babilas P; Karrer S; Landthaler M; Szeimies RM
Clin Exp Dermatol; 2010 Oct; 35(7):792-3. PubMed ID: 20345992
[No Abstract] [Full Text] [Related]
33. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Hyrich KL; Lunt M; Watson KD; Symmons DP; Silman AJ;
Arthritis Rheum; 2007 Jan; 56(1):13-20. PubMed ID: 17195186
[TBL] [Abstract][Full Text] [Related]
34. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
Haennig A; Bonnet D; Thebault S; Alric L
Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
[No Abstract] [Full Text] [Related]
35. Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.
Sprakes MB; Hamlin PJ; Warren L; Greer D; Ford AC
J Crohns Colitis; 2011 Aug; 5(4):324-31. PubMed ID: 21683302
[TBL] [Abstract][Full Text] [Related]
36. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years.
Agarwala S; Shah SB
J Arthroplasty; 2011 Oct; 26(7):1128-34. PubMed ID: 21256699
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy during adalimumab use for psoriasis.
Dessinioti C; Stefanaki I; Stratigos AJ; Kostaki M; Katsambas A; Antoniou C
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):738-9. PubMed ID: 20569288
[No Abstract] [Full Text] [Related]
38. Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab.
Sànchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N; Ruiz-Villaverde R
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S128. PubMed ID: 17067448
[No Abstract] [Full Text] [Related]
39. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.
Seymour MW; Home DM; Williams RO; Allard SA
Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796
[No Abstract] [Full Text] [Related]
40. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
